Journal
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Volume 380, Issue 3, Pages 467-471Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2009.01.108
Keywords
Streptococcus pneumoniae; Pseudomonas aeruginosa; Neuraminidase; Crystal structure; Pneumonia
Categories
Funding
- NHRMC
- Thrasher Research Fund
- Deans Pilot Grant Columbia University
- Cystic Fibrosis Foundation
Ask authors/readers for more resources
Currently there is pressing need to develop novel therapeutic agents for the treatment of infections by the human respiratory pathogens Pseudomonas aeruginosa and Streptococcus pneumoniae. The neuraminidases of these pathogens are important for host colonization in animal models of infection and are attractive targets for drug discovery. To aid in the development of inhibitors against these neuraminidases, we have determined the crystal structures of the A aeruginosa enzyme NanPs and S. pneumoniae enzyme NanA at 1.6 and 1.7 angstrom resolution, respectively. in situ proteolysis with trypsin was essential for the crystallization Of Our recombinant NanA. The active site regions of the two enzymes are strikingly different. NanA contains a deep pocket that is similar to that ill canonical neuraminidases, while the NanPs active site is much more open. The comparative studies Suggest that WON may not be a classical neuraminidase, and may have distinct natural substrates and physiological functions. This work represents an important step in the development Of drugs to prevent respiratory tract colonization by these two pathogens. (C) 2009 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available